tenk.fyi

Lineage Cell Therapeutics, Inc.

LCTXNYSE· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$14.6M

53.2% YoY

Net Income

-$63.5M

241.4% YoY

EPS

$-0.28

211.1% YoY

Cash

$40.8M

10.9% YoY

FY 2025 · As of 2025-12-31